These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 12618238)
1. Differential activation of matrix metalloproteinases in heart failure with and without ventricular dilatation. Nishikawa N; Yamamoto K; Sakata Y; Mano T; Yoshida J; Miwa T; Takeda H; Hori M; Masuyama T Cardiovasc Res; 2003 Mar; 57(3):766-74. PubMed ID: 12618238 [TBL] [Abstract][Full Text] [Related]
2. Activation of matrix metalloproteinases precedes left ventricular remodeling in hypertensive heart failure rats: its inhibition as a primary effect of Angiotensin-converting enzyme inhibitor. Sakata Y; Yamamoto K; Mano T; Nishikawa N; Yoshida J; Hori M; Miwa T; Masuyama T Circulation; 2004 May; 109(17):2143-9. PubMed ID: 15051632 [TBL] [Abstract][Full Text] [Related]
3. Estrogen improves TIMP-MMP balance and collagen distribution in volume-overloaded hearts of ovariectomized females. Voloshenyuk TG; Gardner JD Am J Physiol Regul Integr Comp Physiol; 2010 Aug; 299(2):R683-93. PubMed ID: 20504902 [TBL] [Abstract][Full Text] [Related]
4. Excessive activation of matrix metalloproteinases coincides with left ventricular remodeling during transition from hypertrophy to heart failure in hypertensive rats. Iwanaga Y; Aoyama T; Kihara Y; Onozawa Y; Yoneda T; Sasayama S J Am Coll Cardiol; 2002 Apr; 39(8):1384-91. PubMed ID: 11955860 [TBL] [Abstract][Full Text] [Related]
5. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat. Peterson JT; Li H; Dillon L; Bryant JW Cardiovasc Res; 2000 May; 46(2):307-15. PubMed ID: 10773235 [TBL] [Abstract][Full Text] [Related]
6. Pravastatin increases survival and suppresses an increase in myocardial matrix metalloproteinase activity in a rat model of heart failure. Ichihara S; Noda A; Nagata K; Obata K; Xu J; Ichihara G; Oikawa S; Kawanishi S; Yamada Y; Yokota M Cardiovasc Res; 2006 Feb; 69(3):726-35. PubMed ID: 16165109 [TBL] [Abstract][Full Text] [Related]
7. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure. Kobayashi M; Machida N; Mitsuishi M; Yamane Y Am J Hypertens; 2004 Dec; 17(12 Pt 1):1112-9. PubMed ID: 15607617 [TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase-1 and -2 levels are differently regulated in acute exacerbation of heart failure in patients with and without left ventricular systolic dysfunction. Naito Y; Tsujino T; Lee-Kawabata M; Matsumoto M; Ezumi A; Nakao S; Goda A; Ohyanagi M; Masuyama T Heart Vessels; 2009 May; 24(3):181-6. PubMed ID: 19466518 [TBL] [Abstract][Full Text] [Related]
9. Extracellular matrix remodeling attenuated after experimental postinfarct left ventricular aneurysm repair. Hsu CP; Huang CY; Wang JS; Sun PC; Shih CC Ann Thorac Surg; 2008 Oct; 86(4):1243-9. PubMed ID: 18805169 [TBL] [Abstract][Full Text] [Related]
10. Temporal changes in myocardial collagen, matrix metalloproteinases, and their tissue inhibitors in the left ventricular myocardium in experimental chronic mitral regurgitation in rodents. Corporan D; Onohara D; Hernandez-Merlo R; Sielicka A; Padala M Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1269-H1278. PubMed ID: 30141979 [TBL] [Abstract][Full Text] [Related]
11. MMP/TIMP expression in spontaneously hypertensive heart failure rats: the effect of ACE- and MMP-inhibition. Li H; Simon H; Bocan TM; Peterson JT Cardiovasc Res; 2000 May; 46(2):298-306. PubMed ID: 10773234 [TBL] [Abstract][Full Text] [Related]
12. Alterations in the pattern of collagen deposition may contribute to the deterioration of systolic function in hypertensive patients with heart failure. López B; González A; Querejeta R; Larman M; Díez J J Am Coll Cardiol; 2006 Jul; 48(1):89-96. PubMed ID: 16814653 [TBL] [Abstract][Full Text] [Related]
14. Ethanol extract from Epimedium brevicornum attenuates left ventricular dysfunction and cardiac remodeling through down-regulating matrix metalloproteinase-2 and -9 activity and myocardial apoptosis in rats with congestive heart failure. Song YH; Li BS; Chen XM; Cai H Int J Mol Med; 2008 Jan; 21(1):117-24. PubMed ID: 18097624 [TBL] [Abstract][Full Text] [Related]
15. Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. Li YY; McTiernan CF; Feldman AM Cardiovasc Res; 2000 May; 46(2):214-24. PubMed ID: 10773225 [TBL] [Abstract][Full Text] [Related]
17. Long-term administration of amlodipine prevents decompensation to diastolic heart failure in hypertensive rats. Nishikawa N; Masuyama T; Yamamoto K; Sakata Y; Mano T; Miwa T; Sugawara M; Hori M J Am Coll Cardiol; 2001 Nov; 38(5):1539-45. PubMed ID: 11691537 [TBL] [Abstract][Full Text] [Related]
18. Regulation of matrix metalloproteinases and their inhibitors in the left ventricular myocardium of patients with aortic stenosis. Fielitz J; Leuschner M; Zurbrügg HR; Hannack B; Pregla R; Hetzer R; Regitz-Zagrosek V J Mol Med (Berl); 2004 Dec; 82(12):809-20. PubMed ID: 15558223 [TBL] [Abstract][Full Text] [Related]
19. Estrogen effects on MMP-13 and MMP-14 regulation of left ventricular mass in Dahl salt-induced hypertension. Dai Q; Lin J; Craig T; Chou YM; Hinojosa-Laborde C; Lindsey ML Gend Med; 2008 Mar; 5(1):74-85. PubMed ID: 18420168 [TBL] [Abstract][Full Text] [Related]
20. Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target. Spinale FG; Coker ML; Bond BR; Zellner JL Cardiovasc Res; 2000 May; 46(2):225-38. PubMed ID: 10773226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]